Proteomic characterization of the cellular response to chemopreventive triterpenoid astragaloside IV in human hepatocellular carcinoma cell line HepG2

Pharmacology, Toxicology and Pharmaceutical Science

• Antibody 16%
• Astragaloside IV 100%
• Astragalus Root 16%
• Carcinogenesis 16%
• Cell Protein 33%
• Liver Cell Carcinoma 33%
• Malignant Neoplasm 33%
• Pharmaceutical Therapy 16%
• Polyacrylamide Gel Electrophoresis 16%
• Primer DNA 16%
• Protein 33%
• Survival 33%
• Triterpenoid 66%
• Western Blot 33%

Chemistry

• Astragaloside IV 100%
• Chemopreventive 33%
• Dose 16%
• Mass Spectrometry 33%
• Polyacrylamide Gel Electrophoresis 16%
• Procedure 16%
• Protein 66%
• Time 16%
• Triterpenoid 66%
• Western Blotting 16%

Biochemistry, Genetics and Molecular Biology

• Anchorage Independent Growth 33%
• Antibody 16%
• Antineoplastic Activity 16%
• Cancer Cell 16%
• DNA 16%
• Dose 16%
• down Regulation 16%
• Mass Spectrometry 16%
• Mass Spectrometry 16%
• Oncogene 33%
• Protein 66%
• Proteomics 33%
• Reverse Transcription Polymerase Chain Reaction 16%
• Survival 33%
• Time 16%
• Two-Dimensional Gel Electrophoresis 16%